Rajender Reddy
Internal Medicine · Hammonton, NJNPI 1467505784
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $80,750 of the $96,441 with a category attached, or 83.7%. Novo Nordisk accounts for 73.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $32,853 and has fallen 94.0% since, to $1,963 in 2025. Among internal medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $2537.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$71K
- Pfizer$10K
- Mallinckrodt Hospital Products Inc.$6K
- Astrazeneca UK Limited$6K
- Novo Nordisk AS$2K
- Deciphera Pharmaceuticals Inc.$930
- plus $510 from 1 others
Across 197 payments — averaging $3812.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$327K
- Intercept Pharmaceuticals, Inc.$220K
- Bausch Health US, LLC$88K
- Grifols Therapeutics LLC$86K
- Intercept Pharma Europe Ltd.$20K
- Grifols Biologicals LLC$8K
- plus $1K from 1 others
What the payments were for
- Consulting fees$80,75084%
- Travel & lodging$14,66115%
- Food & beverage$1,0311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $70,970 |
| Pfizer | 4 | $10,406 |
| Mallinckrodt Hospital Products Inc. | 2 | $5,799 |
| Astrazeneca UK Limited | 4 | $5,500 |
| Novo Nordisk AS | 1 | $2,325 |
| Deciphera Pharmaceuticals Inc. | 1 | $930 |
| Spark Therapeutics, Inc. | 4 | $510 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$96,441 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 22 | $363 |
| Pantoprazole Sodium | 12 | $186 |
| Lisinopril | 12 | $136 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hammonton
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.